Net loss for the quarter was $7.9 million, compared to net income of $233,000 in the prior year period, primarily due to ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...

Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...

Don’t apply solely to work with one person. Faculty members change institutions, often unexpectedly. Sometimes they change ...

KORE (NYSE:KORE) suspended financial guidance for the remainder of fiscal year 2025 due to uncertainty from the announced ...

Precigen, Inc. ( PGEN) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Update ...

Pre-enrollment is currently being held for those students who are new to the School District of Lee County for the 2026-27 ...

Q3 2025 Earnings Call Transcript November 12, 2025 GLOBALFOUNDRIES Inc. beats earnings expectations. Reported EPS is $0.41, ...

The Forest/Warren Court of Common Pleas is reminding those who plan to appeal their real estate assessment of Local Rule 5003, which governs appeals from real estate assessment. The rule is reprinted ...

What is old is new again, and Modular Open Systems Approach (MOSA) is no different. MOSA is an acquisition and design ...

Before proceeding, let me mention that any forward-looking statements included in the presentation or mentioned in this ...